Scorpius Holdings Inc (SCPX)

Scorpius Holdings, Inc. operates through its subsidiary Scorpius BioManufacturing as an integrated contract development and manufacturing organization. It produces drug substance for clinical trials and commercial use and performs release and stability testing. It also offers process development, including upstream and downstream development and optimization, analytical method development, and cell line development, testing and characterization.

Its customers are biotechnology and biopharmaceutical companies. Formerly NightHawk Biosciences, Inc., the company changed its name in February 2024. It was incorporated in 2008 and is based in San Antonio, Texas.